Mycobacterium goodii pulmonary disease with organizing pneumonia: A case report and review of literature.

IF 0.8 Q4 RESPIRATORY SYSTEM
Respirology Case Reports Pub Date : 2025-01-04 eCollection Date: 2025-01-01 DOI:10.1002/rcr2.70095
Yu Shionoya, Hajime Kasai, Reiya Kono, Ryutaro Hirama, Masayuki Ota, Akira Naito, Mitsuhiro Abe, Takeshi Kawasaki, Jun-Ichiro Ikeda, Takuji Suzuki
{"title":"<i>Mycobacterium goodii</i> pulmonary disease with organizing pneumonia: A case report and review of literature.","authors":"Yu Shionoya, Hajime Kasai, Reiya Kono, Ryutaro Hirama, Masayuki Ota, Akira Naito, Mitsuhiro Abe, Takeshi Kawasaki, Jun-Ichiro Ikeda, Takuji Suzuki","doi":"10.1002/rcr2.70095","DOIUrl":null,"url":null,"abstract":"<p><p><i>Mycobacterium goodii</i>, a rapidly growing non-tuberculous mycobacterium, rarely causes pulmonary diseases. A patient was admitted to our hospital with a fever and cough. Chest radiography revealed consolidation in the right middle lung. As he had previously been treated for organizing pneumonia (OP), he was diagnosed with OP recurrence and administered systemic corticosteroids. Although initial improvement was observed, the pulmonary consolidations worsened. Transbronchial lung cryobiopsy revealed an OP pattern. <i>M. goodii</i> was identified in sputum acid-fast bacilli cultures. The patient was diagnosed with <i>M. goodii</i> pulmonary disease and secondary OP. Although intravenous imipenem-cilastatin, amikacin, and ciprofloxacin led to initial improvement in pulmonary consolidations, the consolidations re-worsened. Systemic corticosteroids were initiated, resulting in improvement in the consolidations. The dose of systemic corticosteroids was tapered; oral antimycobacterial therapy was continued. <i>M. goodii</i> can cause pulmonary disease and induce OP; antimycobacterial therapy and systemic corticosteroids can be effective.</p>","PeriodicalId":45846,"journal":{"name":"Respirology Case Reports","volume":"13 1","pages":"e70095"},"PeriodicalIF":0.8000,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702367/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respirology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/rcr2.70095","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Mycobacterium goodii, a rapidly growing non-tuberculous mycobacterium, rarely causes pulmonary diseases. A patient was admitted to our hospital with a fever and cough. Chest radiography revealed consolidation in the right middle lung. As he had previously been treated for organizing pneumonia (OP), he was diagnosed with OP recurrence and administered systemic corticosteroids. Although initial improvement was observed, the pulmonary consolidations worsened. Transbronchial lung cryobiopsy revealed an OP pattern. M. goodii was identified in sputum acid-fast bacilli cultures. The patient was diagnosed with M. goodii pulmonary disease and secondary OP. Although intravenous imipenem-cilastatin, amikacin, and ciprofloxacin led to initial improvement in pulmonary consolidations, the consolidations re-worsened. Systemic corticosteroids were initiated, resulting in improvement in the consolidations. The dose of systemic corticosteroids was tapered; oral antimycobacterial therapy was continued. M. goodii can cause pulmonary disease and induce OP; antimycobacterial therapy and systemic corticosteroids can be effective.

gooddii分枝杆菌肺部疾病合并组织性肺炎1例报告及文献复习。
良地分枝杆菌是一种生长迅速的非结核分枝杆菌,很少引起肺部疾病。一个病人因发烧和咳嗽而住进我们医院。胸片显示右中肺实变。由于他之前曾接受过组织性肺炎(OP)的治疗,他被诊断为OP复发并给予全身皮质类固醇治疗。虽然观察到最初的改善,但肺实变恶化。经支气管肺低温活检显示OP型。在痰抗酸杆菌培养中鉴定出古地分枝杆菌。患者被诊断为古地弓形虫肺病和继发性阻塞性肺病。尽管静脉注射亚胺培南-西司他汀、阿米卡星和环丙沙星可使肺实变初步改善,但实变再次恶化。开始全身性皮质类固醇治疗,改善了实变。全身皮质类固醇的剂量逐渐减少;继续口服抗真菌治疗。古地弓形虫可引起肺部疾病并诱发OP;抗细菌治疗和全身皮质类固醇是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Respirology Case Reports
Respirology Case Reports RESPIRATORY SYSTEM-
CiteScore
1.40
自引率
0.00%
发文量
178
审稿时长
8 weeks
期刊介绍: Respirology Case Reports is an open-access online journal dedicated to the publication of original clinical case reports, case series, clinical images and clinical videos in all fields of respiratory medicine. The Journal encourages the international exchange between clinicians and researchers of experiences in diagnosing and treating uncommon diseases or diseases with unusual presentations. All manuscripts are peer-reviewed through a streamlined process that aims at providing a rapid turnaround time from submission to publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信